October 28, 2010 – An initial feasibility study has demonstrated the ability to use cesium-131 (Cs-131) brachytherapy seeds in accelerated partial breast irradiation (APBI) for breast cancer treatment. The study looked at IsoRay’s patented therapy for treating early stage, localized breast cancer.
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now